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ABSTRACT
Objective: To examine how the population with
fractured neck of femur has changed over the last
decade and determine whether they have evolved to
become a more physically and socially dependent
cohort.
Design: Retrospective cohort study of prospectively
collected Standardised Audit of Hip Fractures of Europe
data entered on to an institutional hip fracture registry.
Participants: 10 044 consecutive hip fracture
admissions (2000–2012).
Setting: A major trauma centre in the UK.
Results: There was a generalised increase in the
number of admissions between 2000 (n=740) and
2012 (n=810). This increase was non-linear and best
described by a quadratic curve. Assuming no change
in the prevalence of hip fracture over the next 20 years,
our hospital is projected to treat 871 cases in 2020
and 925 in 2030. This represents an approximate year-
on-year increase of just over 1%. There was an
increase in the proportion of male admissions over the
study period (2000: 174 of 740 admissions (23.5%);
2012: 249 of 810 admissions (30.7%)). This mirrored
national census changes within the geographical area
during the same period. During the study period there
were significant increases in the numbers of patients
admitted from their own home, the proportion of
patients requiring assistance to mobilise, and the
proportion of patients requiring help with basic
activities of daily living (all p<0.001). There was also a
twofold to fourfold increase in the proportion of
patients admitted with a diagnosis of cardiovascular
disease, renal disease, diabetes and polypharmacy (use
of >4 prescribed medications; all p<0.001).
Conclusions: The expanding hip fracture population
has increasingly complex medical, social and
rehabilitation care needs. This needs to be recognised
so that appropriate healthcare strategies and service
planning can be implemented. This epidemiological
analysis allows projections of future service need in
terms of patient numbers and dependency.
INTRODUCTION
The UK currently treats approximately
80 000 hip fractures every year at an
estimated annual cost of two billion pounds
in direct healthcare costs alone.1–3 One in
every 12 patients who sustains a hip fracture
will die in the ﬁrst month following injury
and three in every 10 will die within the ﬁrst
year.3 The WHO has estimated that the
number of people aged 65 and over will
increase by 88% over the next 25 years due
to an aging world population, better public
health and an increased use of medical inter-
ventions that prolong the average life expect-
ancy.4 Despite a decline in the age-speciﬁc
incidence of hip fractures over the last
decade5–7 these population changes mean
the overall number of hip fractures will con-
tinue to increase.5 6 The annual number of
hip fractures in the UK is projected to rise to
91 500 by 2015 and 101 000 by 2020.6
Strengths and limitations of this study
▪ This analysis is based on 10 044 consecutive hip
fracture admissions over a 13-year period from a
defined geographical area using standardised
data collection.
▪ Trends in the hip fracture population including
information on patient demographics, medical
comorbidities, physical functioning, social cir-
cumstances and cognitive capacity during this
period are presented.
▪ On the basis of these data we have been able to
produce a simplified equation that allows individ-
ual centres to calculate their own expected
increases in hip fracture admissions over the
next 20 years.
▪ This is a retrospective analysis and there may be
issues relating to coding inaccuracies and
recorder bias.
▪ Any projections to a national population of hip
fractures from a single centre, single population
study may be liable to regional discrepancies
and may not be applicable to other hospital
populations where incidence of, for example,
other comorbidities may be significantly
different.
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The projected rise in hip fracture incidence has impli-
cations for health strategy and resource allocation.
These must be addressed if we are to continue to
manage the speciﬁc needs of these patients and improve
the standard of care. Previous studies have evaluated
how hip fracture incidence has changed with time,5–7
the relationships to changing population demographics5
and the impact on projected future healthcare require-
ments.8–10 Few, if any, studies have evaluated how phys-
ical dependency, medical comorbidities, social needs
and care requirements have changed within this popula-
tion with time. This is important to appreciate as these
factors will also have a signiﬁcant impact on the require-
ments for future medical, nursing, rehabilitation and
social services.
To address these concerns we interrogated an institu-
tional hip fracture database with the aim of answering
the following research question: ‘How has the popula-
tion of patients admitted to hospital with a fractured
neck of femur changed over the last decade and have
they evolved to become a more physically and socially
dependent cohort?’. Our null hypothesis was that the
population with fractured neck of femur would not have
changed with time for any of the markers of physical
and social dependency examined during this analysis.
PATIENTS AND METHODS
The Nottingham Hip Fracture Database
Nottingham University Hospitals cover a catchment
population of approximately 785 000 and admit approxi-
mately 800 hip fractures each year. For the entire study
period, it has been the only hospital providing a trauma
service for the local population and its surrounding
areas. In May 1999, the Nottingham Hip Fracture
Database was initiated to prospectively collect informa-
tion on all patients with hip fracture for the purpose of
an ongoing audit and service evaluation. Data for all
patients with hip fracture are recorded using a modiﬁed
version of the Standardised Audit of Hip Fractures of
Europe (SAHFE) data collection form.4 All data are col-
lected prospectively by a team of independent audit staff
who administer the local hip fracture database. SAHFE
data completion is mandatory for all hip fractures in our
hospital and in 2012 the trust recorded over 93% in the
domain of data completeness within the National Hip
Fracture Database (NHFD).11 Audit data are strictly con-
ﬁdential and are managed in accordance with national
data protection (Caldicott) guidelines.
Study design and dataset
To address our research question a retrospective cohort
study was conducted using all of the information held
within the hip fracture database from its inception (May
1999) to the date of the current project data request
(March 2013). In total 10 739 consecutive hip fracture
admissions were identiﬁed. From this cohort we
excluded the cases from 1999 (n=446) and 2013
(n=249) as a complete years’ worth of admission data
were not available. Analysis was therefore based on a
consecutive series of 10 044 hip fractures admitted
during a 13-year period between the 1 January 2000 and
31 December 2012. The baseline demographics for
study cohort are given in table 1.
Outcome variables
The Nottingham Hip Fracture Database records infor-
mation on patient demographics, medical comorbidities,
physical functioning, social circumstances and cognitive
capacity for each patient with hip fracture. The database










Cardiovascular disease 4851 (48)
Cerebrovascular disease 1442 (14)
Chronic obstructive airways disease 1426 (17)
Renal disease 614 (6)
Diabetes mellitus 1242 (12)
Rheumatoid arthritis 350 (3)






Own home 6742 (67)
Warden aided/residential home 1952 (19)
Nursing home 1101 (11)
Hospital inpatient 127 (1)
Rehabilitation facility 26 (0)
Other 77 (1)
Unknown 19 (0)
Walking ability (yes (%))
Independent outdoors 5027 (50)
Independent indoors 2443 (24)
Accompanied outdoors 1302 (13)
Accompanied indoors 561 (6)
Unable to mobilise/transfers only 261 (3)
Unknown 450 (5)
Walking aids (yes (%))
No aids 4434 (44)
One or more aids 3086 (31)
Frame/walker 2009 (20)
Wheelchair/bed user 293 (3)
Unknown 222 (2)




Other (eg, reverse oblique) 305 (3)
Unknown 3 (0)
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records information pertaining to speciﬁc comorbidities,
including questions about the presence of a diagnosis of
cardiovascular disease (CVD), cerebrovascular disease,
chronic obstructive pulmonary disease, renal disease,
diabetes mellitus (DM), rheumatoid arthritis,
Parkinson’s disease and malignancy. During the study
period there was no change in the deﬁnitions used by
the database for each of these conditions. Information
about medication use is also recorded, with speciﬁc
questions about the use of steroids, anticoagulants (eg,
clopidogrel and warfarin) and polypharmacy (the use of
>4 regular medications; table 1).
Physical functioning is assessed using speciﬁc ques-
tions related to mobility status, independence within
and outside the house and ability to perform activities
of daily living (ADLs) such as washing, dressing, clean-
ing, feeding and toileting. Social circumstances are
assessed by questions relating to the type of residence,
cohabitation and the requirement for additional carers.
The abbreviated mental test score is used to assess cogni-
tive capacity.12
To ascertain how the hip fracture population had
changed with time, the distribution of each of these
outcome variables was calculated for each year of the
analysis (2000–2012). This allowed observed changes
and trends in the distributional characteristics of these
variables with time to be appreciated.
Statistical analysis
Initial graphical and tabular summaries were performed
to demonstrate how the hip fracture population
changed over the period of analysis. Comparison with
publically available Nottingham census data (2001 and
2011) was conducted to see if the observed changes in
the hip fracture population mirrored those seen for the
general population.
Statistical comparisons were performed to determine
if each of the analysed variables changed over the
period of observation. For continuous parametric data
comparisons were made using independent t tests and
one-way analysis of variance. For continuous non-
parametric data comparisons were made using
Mann-Whitney and Kruskal-Wallis tests. For categorical
data Fishers exact and χ2 tests were used. A p value of
p<0.05 was used to indicate statistical signiﬁcance.
Time series analysis was used to produce a mathemat-
ical model for the year-on-year changes in the observed
number of hip fracture admissions. Linear, quadratic,
exponential and S-Curve models were sequentially ﬁtted
to the data and for each model its adequacy was assessed
using the mean absolute percentage error, mean abso-
lute deviation and the mean squared deviation. The
‘best ﬁt’ quadratic time series model was selected as it
was the model type that minimised each of these vari-
ables. This model was then used to generate forecasts of
the expected number of admissions in 2020, 2025 and
2030. Statistical analysis was performed using SPSS V.19
(IBM Corporation, Armonk, USA) and the time series




During the period 2000–2012 a total of 10 044 patients
were admitted with a hip fracture. The mean number of
admissions per year was 773 (SD 44.9, range 704–854)
with a generalised increase in the number of hip fracture
admissions each year. This increase was non-linear and
best described by the quadratic curve: admissions=715.59
+(8.72×number of years after 1999)−(0.06×(number of
years after 1999)2), (ie, year 2000 = 1; ﬁgure 1). Assuming
no change in the prevalence of hip fracture over the next
20 years, our hospital is projected to treat 871 cases in
2020, 899 in 2025 and 925 in 2030. A simple equation to
allow hip fracture units to estimate their future hip frac-
ture numbers (assuming similar demographics to
Nottingham) is shown in ﬁgure 1.
Patient demographics
Baseline demographics for the entire study cohort are
presented in table 1.
Age at admission did not signiﬁcantly change during
the period of study (p=0.67). However the median age
of women (83 years (IQR 77–88, range 19–105 years))
was signiﬁcantly higher than that for men (80 years
(IQR 70–86, range 17–105 years; p<0.001)). While they
differed, the age distributions of male and female
patients did not signiﬁcantly change with time (compari-
son across all years: female p=0.70, male p=0.11). During
the period of study there was a steady and signiﬁcant
increase in the proportion of male admissions from 174
of 740 (24%) in 2000 to 249 of 810 (31%) in 2012
(p<0.001; table 2).
Figure 1 Number of hip fracture admissions 2000–2012 with
‘best fit’ time series model (red line: admissions=715.59
+(8.72×number of years after 1999)−(0.06×(number of years
after 1999)2), ie, year 2000=1). Green line represents the
forecasted number of admissions based on this model beyond
2030. Hip fracture admissions can be approximated in any
hospital using a simplified equation based on this model:
predicted admissions in year X=admissions in specified unit in
2012+(0.01×admissions in specified unit in 2012×(X−2012))
−(0.0001×admissions in specified unit in 2012×(X−2012)2).
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Comorbidities
Of the comorbidities recorded there was a signiﬁcant
increase in the proportion of patients presenting with
CVD, DM, renal disease and polypharmacy (patients on
greater than 4 prescribed medications) with time (ﬁgure
2). In 2000, the percentage of patients with CVD was 20%
(145 of 740 admissions), which increased by a factor of
3.1 to 61% in 2012 (497 of 810 admissions; p<0.001).
Similarly the percentage of patients with DM increased
by a factor of 1.8 from 9% (64 of 740 admissions) in 2000
to 15% (125 of 810 admissions) in 2012 (p<0.001). The
presence of renal disease increased from 2% (15 of 740
admissions) in 2000 to 9% (69 of 840 admissions) in
2012, a greater than fourfold increase (p<0.001). The
proportion of patients with polypharmacy also increased
by a factor of two between 2000 (20%, 142 of 740 admis-
sions) and 2012 (40%, 322 of 810 admissions; p<0.001).
For all other recorded comorbidities the proportions of
admissions with a positive diagnosis remained similar
throughout the period of observation.
The median abbreviated mental test score for patients
was 9 (IQR 3–10, range 0–10) and did not change sig-
niﬁcantly year to year (p=0.51). The number of patients
prescribed either clopidogrel or warfarin demonstrated
signiﬁcant variation from year to year and followed a
steadily increasing trend between 2000 and 2012 (both
p<0.001; ﬁgure 3).
Social demographics
Baseline social demographic data are presented in
table 1. Between 2000 and 2012 there was a gradual
increase in the number of admissions of patients living
in their own homes (p<0.001). Over the same time
period there was a reciprocal decrease in admissions
from warden-aided/residential care and nursing care
(p<0.001; ﬁgure 3). Of the 6742 patients living in their
own homes 3278 (49%) lived alone. The proportion of
patients living alone in their own homes remained
similar over the period of observation (table 2).
At the time of admission 5027 of the 10 044 (50%)
admissions mobilised independently outdoors (table 1).
Of these 5027 patients 3119 (62%) did not use any mobil-
ity aids, 1520 (30%) used one aid and 388 (8%) used two
aids/frame/walker. The reliance on walking aids
increased as the level of mobility decreased (p<0.001).
The proportion of patients mobilising independently out-
doors at the time of admission increased signiﬁcantly
between 2000 and 2012. During the same period there
was a reciprocal decrease in the proportion of patients
mobilising independently indoors (p<0.001; table 2).
The proportions of patients who were completely
independent for all ADLs were similar across the study
period (table 2). Overall 4011 of 10 044 (40%) patients
were completely independent for all ADLs. For the 6033
patients who were not independent for their ADLs, 2586




p Value*2000 2004 2008 2012
N 740 761 758 810
Median age (years) (IQR) 81 (75–87) 81 (74–87) 82 (75–87) 82 (75–87) 0.06
Gender (%)
Male:female 174 (24):566 (76) 173 (23):588 (77) 206 (27):552 (73) 249 (31):261 (69) <0.001
Median Abbreviated Mental
Test Score (IQR)
8 (2–10) 8 (2–10) 8 (2–10) 7 (2–10) 0.51
Residence (yes (%))
Own home 463 (63) 505 (66) 537 (71) 587 (73) <0.001
Warden aided/residential home 171 (23) 161 (21) 127 (17) 149 (18)
Nursing home 98 (13) 74 (10) 75 (10) 66 (8)
Other/unknown 8 (1) 13 (2) 19 (3) 8 (1)
Living alone in own home 234 of 463 (51) 263 of 505 (52) 261 of 537 (49) 301 of 587 (51) 0.49
Walking ability (yes (%))
Independent outdoors 343 (46) 385 (51) 400 (53) 429 (53) <0.001
Independent indoors 301 (41) 201 (26) 126 (17) 129 (16)
Accompanied outdoors 33 (4) 101 (13) 128 (17) 120 (15)
Accompanied indoors 46 (6) 39 (5) 35 (5) 42 (5)
Unable to mobilise/transfers only 14 (2) 26 (3) 20 (3) 33 (4)
Unknown 3 (0) 9 (1) 49 (6) 57 (7)
Independent for all ADLs (%) 455 (61%) 488 (64%) 441 (58%) 460 (57%) 0.02
Requires assistance with basic care (%)
(washing, dressing, feeding, toileting)
162 (22%) 240 (32%) 181 (24%) 220 (27%) <0.001
*Comparison of variation in factors for all years with the analysis.
ADL, activities of daily living.
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(43%) required assistance with some form of basic care
(washing, dressing, feeding, toileting; ﬁgure 4). The pro-
portion of patients requiring this level of care increased
from 161 of 455 patients requiring assistance with ADLs
(36%) in 2000 to 220 of 460 patients requiring assist-
ance with ADLs (48%) in 2012 (p<0.001).
Fracture demographics
The distributions of the type of fractures presenting
to the unit by year are shown in ﬁgure 5 and given
in table 1. The distribution of intracapsular and
extracapsular (intertrochanteric/subtrochanteric/other
proximal femoral fractures) remained consistent over
the period of study with approximately 60% of hip
fractures/year being intracapsular.
DISCUSSION
Principle findings and comparison with other studies
The last decade has seen an increase in the number of
hip fractures admitted to our institution. The number of
admissions is expected to increase further over the next
20 years with a forecasted 15% rise in admissions by
2030. However, while the number of admissions is
increasing, the quadratic time series curve produced
suggested that, the size of the annual increase is redu-
cing year on year. Using our data we have produced a
simpliﬁed forecasting model which was ±1% accurate
when compared to the predicted results from the time
series curve. This equation can be used by centres
wanting to calculate their expected short-term to
mid-term hip fracture service requirements.
The predicted rise in the number of hip fractures
mirrors the trends predicted for England5 and
Scotland.6 However, the size of the increase is smaller
than the 45–75% rise in numbers predicted by the
Scottish group6 and signiﬁcantly lower than the ‘pessim-
istic’ estimate of a doubling in the number of hip frac-
tures by 2033 reported for England by White and
Grifﬁths.5 Hip fracture admissions are expected to con-
tinue to rise despite a global decrease in the age-related
incidence of these fractures during the last decade.5 7
This is because the population continues to age due to
the success of public health strategies and the advent of
medical interventions, that prolong the average life
expectancy, during the second half of the 20th
century.4 13 In 2011 approximately 1 in 5 (22.6%) of the
population of England and Wales was aged over 60 and
the total number of residents aged over 90 was 430 000,
up from 340 000 in 2001.14 Between 2001 and 2011 the
population of Nottinghamshire increased by 37 500 (5%)
from 748 300 (2001) to 785 800 (2011) with an associated
3% increase in the proportion of the population aged
over 60 (21.1% in 2001, 24.1% in 2011).15 16 This may
Figure 2 Trends in the proportion of patients admitted with
cardiovascular disease (CVD), diabetes mellitus (DM), renal
disease (renal) and polypharmacy (4+ meds) between 2000
and 2012.
Figure 3 Number of admissions
that were prescribed either
clopidogrel (C) or warfarin (W).
Percentages represent the
proportion of admissions that
were taking either of these agents
in each year.
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explain the observed 10% increase in the number of hip
fracture admissions to our unit over the same time period
and the relatively conservative estimate for the number of
future admissions. Geographical areas with greater
increases in the proportion of their population over 60
are likely to experience greater increases in hip fracture
admissions in future years. Our equation for predicting
future clinical need must therefore be interpreted in the
context of each individual centre’s geographical popula-
tion and will be most accurate for centres that service
patient populations similar to our own.
The median age of our cohort did not change with
time, however, the proportion of male admissions
increased. This contrasts with the review by Haleem
et al13 which found a trend towards an increasing mean
age and a static female:male ratio in the 36 publications
they reviewed pertaining to hip fractures between 1959
and 1998. Similarly the 2013 NHFD report demonstrates
an increase in the proportion of hip fractures in the very
elderly (>90 years) with a static female:male ratio
between 2009 and 2013.11 Census data for Nottingham
suggest that between 2001 and 2011 there was a large
increase in the number of male patients aged 75–
89 years living within the hospital’s catchment area15 16
helping to explain these differing ﬁndings and the
increasing number of male admissions observed within
our cohort.
Between 2000 and 2012 we observed a number of sig-
niﬁcant changes in the hip fracture population. At the
end of the period a greater number of patients were
living alone in their own homes, requiring assistance
with basic ADLs, and presenting with signiﬁcant medical
comorbidities. This increase in the levels of physical and
social dependence has implications for the delivery of
the hip fracture service. As a result of these changes we
can expect to see increases in the rates of postoperative
mortality, morbidity and length of hospital stay.5 6 White
and Grifﬁths5 predicted that, as the population ages,
30-day mortality rates will rise from 8.3% in 2008 to
9.3% by 2033, resulting in 7000 additional deaths each
year. This effect is likely to be compounded by the
increasing frailty observed in this study, and if these
trends continue this estimate may need to be revised
upward. These changes also suggest that we are support-
ing a population of patients who are increasingly frail
and have signiﬁcant social care needs within their own
homes. This has implications for acute nursing care,
postoperative rehabilitation and eventual discharge plan-
ning. Patients are less likely to achieve the requisite level
of physical functioning to permit discharge home if they
have poor functional reserve to begin with. They are
also less likely to get home if they are socially isolated
and require increased levels of social care. There are
also implications for benchmarking and audit systems,
such as the NHFD and the Nottingham Hip Fracture
Score that use living at home versus living in an institu-
tion as a surrogate for frailty.17 18 Our data suggest that
this distinction may be becoming less clear-cut. Such
scores may therefore need recalibration in future years.
Changes in the prevalence of speciﬁc comorbidities
may be a direct manifestation of an increasingly frail
elderly population with declining health. Some of this
effect may be attributable to greater data accuracy as the
hip fracture database matured and administrators
became more familiar with the datasets. However, this is
unlikely to account for the magnitude of the observed
changes in each of the comorbidities. The changing
prevalence may also have been inﬂuenced by the intro-
duction of national guidelines and health policies that
aim to promote evidence-based practice and incentivise
the treatment of a range of chronic conditions in
primary care during the period of study. Initiatives such
as the Quality and Outcome Frameworks19 have been
introduced to reward primary care practices if they
deliver high quality on a range of services.20 Areas of
clinical care linked to rewards include the implementa-
tion of clinical interventions known to beneﬁt patients
with chronic conditions such as CVD, diabetes and
chronic renal disease.21 22 The initiation of such strat-
egies in 2003/2004 may, in part, account for the sudden
Figure 4 Patients requiring assistance with basic care
(washing, dressing, feeding and toileting) as a proportion of all
patients requiring assistance with their activities of daily living
(n=6033).
Figure 5 Distribution in the pattern of presenting fracture by
year (2000–2012).
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jump in proportion of patients we observed with these
comorbidities. In addition, during the study period, the
National Institute for Clinical Excellence23–28 and the
National Service Framework29 have published a range of
guidance which may have increased diagnostic awareness
for these conditions.
Strengths and limitations
This study beneﬁts from the size of the cohort available
for analysis, the consecutive period of follow-up, consist-
ent data collection and the range of data collected. The
hospital serves a well-deﬁned urban/rural population
with no alternative hip fracture service within this geo-
graphical area. During the study period the trauma
service at Nottingham was awarded major trauma centre
status. This is, however, unlikely to have had a signiﬁcant
impact on the number of hip fracture admissions and
our future hip fracture projections as referrals to a
major trauma centre are triggered primarily based on
mechanism of injury. As the majority of hip fractures
occur after low-energy injuries such as fall from standing
height, they should not trigger the major trauma
pathway and should be taken to their nearest ortho-
paedic unit as previously. While the unit’s current data
completeness rate of 93% is good and much better than
Hospital Episode Statistics, it could be better. The intro-
duction of the National Institute for Health and Care
Excellence (NICE) guidance and best practice tariff may
have raised awareness in reporting of facets of patient
care giving more accurate and complete data in the
later years. Inaccuracies in coding and recorder inter-
variability are potential sources of error which may
account for some of the year-on-year differences
observed. Any projections to a national population of
hip fractures from a single centre, single population
study may be liable to regional discrepancies and may
not be applicable to other hospital populations where
incidence of, for example, other comorbidities may be
signiﬁcantly different. In addition our projections for
future admissions are based on static hip fracture inci-
dence whereas current hip fracture incidence is declin-
ing at approximately 0.6% per year.5 While we accept
this may result in the number of hip fracture admissions
being overestimated it was carried out to simplify the
analysis, and the ability of other centres to use the pro-
posed equations. In addition, it is unclear whether this
decrease in prevalence will continue at the same rate
over the next 20 years, or it will decrease further or
increase at some undeﬁned point so that the prevalence
starts to rise. However, despite these concerns we feel
that the overall trends reported here are likely to be gen-
eralisable to national practice. While the NHFD pub-
lishes yearly reports on management of the hip fracture
population it has only been reporting national results
since 2009.11 Despite comprising over 250 000 records
its report contains limited information on dependency
and does not present data on comorbidities.3 11 The
information presented here therefore adds signiﬁcantly
to the results available from this database. Further useful
information is likely to come from the recently under-
taken hip fracture Anaesthesia Sprint Audit Project
(ASAP).30 This audit of 11 000 hip fracture cases will
complement the information presented here by allowing
us to better understand the absolute numbers and the
variation in prevalence of a range of comorbidities, and
the differing ways in which these comorbidities are
treated.
Conclusion
The cost of treating hip fractures is rising.1 5 Currently
the annual cost of treating these injuries is approxi-
mately £2 billion/year which helps to deliver a high-
quality service based on NICE’s recommendations of
surgery performed on dedicated trauma lists within 36 h
of admission, adequate physiotherapy and occupational
therapy provision allowing early mobilisation and
rehabilitation, and ongoing orthogeriatric assessment
and support. However, the projected increase in the
number of hip fractures, combined with more frail,
elderly and socially dependent patients who are likely to
experience greater rates of mortality, postoperative mor-
bidity and longer inpatient stays will drive this ﬁgure up
over the next 20 years. Cost estimates for hip fracture
treatment predict a 243% increase in costs to £5.6
billion by 2033.5 Worryingly we have shown that more
and more patients have complex medical comorbidities
and social needs and so it is likely that the cost of treat-
ing these patients is likely to climb at a faster rate than
these projections based on changes in the age demo-
graphics alone. This must be appreciated to so that
appropriate healthcare strategies and service planning
can be implemented to prevent the hip fracture service
enduring a ﬁnancial shortfall, particularly at a time
when there is an ever increasing drive to meet best prac-
tice targets.
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